Saturday 17 October 2026
Export CARL’s income statement to Excel — free account
Carlsmed, Inc.
CARL Healthcare Health Information Services
Carlsmed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $50.5 million, up 85.9% from fiscal 2024. In the quarter to June 2026, revenue grew 56.8%, EPS grew 73.5%, free cash flow fell 6.84% and total debt was flat, each against the same quarter a year earlier.
13.41
0.54
−3.87%
Follow CARL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+5 more quarters Free account |
P/S ratio |
4.46 | 4.30 | 3.48 | 6.73 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(38.36) | (18.67) | (33.01) | (33.37) | |
P/B ratio |
3.35 | 2.63 | 1.78 | 2.65 | |
Price to Tangible BV |
3.35 | 2.63 | 1.78 | 2.65 | |
EV/Sales |
3.29 | 2.85 | 1.61 | 4.35 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(6.10) | (4.76) | (2.80) | (6.54) | |
EV/FCF |
(5.84) | (4.58) | (2.67) | (6.27) | |
Quick Ratio |
8.32 | 11.26 | 8.49 | 11.60 | |
Current Ratio |
8.84 | 11.88 | 8.87 | 12.03 | |
Net Debt/EBITDA |
6.78 | 8.91 | 10.25 | 11.17 | |
Debt/Assets |
13.01% | 12.94% | 11.79% | 11.45% | |
Debt/Equity |
0.18 | 0.17 | 0.16 | 0.14 | |
Asset Turnover |
0.74 | 0.66 | 0.78 | 0.45 | |
Operating CF/Net income |
0.70 | 1.50 | 0.62 | 0.99 | |
Capex/Depreciation |
(5.76) | (2.08) | (2.35) | (4.18) | |
Interest Coverage |
(35.26) | (29.83) | (28.24) | (23.78) | |
Research and Development Expense of Revenue |
31.89% | 32.13% | 34.71% | 34.00% | |
Selling, General and Administrative Expense of Revenue |
103.16% | 102.53% | 103.28% | 111.04% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
11.99% | 10.11% | 5.21% | 5.38% | |
Graham Net Nets |
0.27 | 0.37 | 0.54 | 0.37 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(13.78%) | (27.73%) | (29.64%) | (39.21%) | |
Free Cash Flow Yield |
(12.64%) | (14.47%) | (17.27%) | (10.29%) | |
Revenue per Share |
0.70 | 0.60 | 1.07 | 0.62 | |
Operating CF per Share |
(0.27) | (0.48) | (0.37) | (0.40) | |
Capex per Share |
(0.03) | (0.01) | (0.02) | (0.02) | |
Free Cash Flow per Share |
(0.30) | (0.49) | (0.39) | (0.42) | |
Cash per Share |
3.29 | 3.62 | 7.73 | 5.48 | |
Shareholders Equity per Share |
3.10 | 3.44 | 6.95 | 5.06 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.10 | 3.44 | 6.95 | 5.06 | |
Free Cash Flow |
(8.11) | (13.21) | (5.55) | (8.80) | |
Working Capital |
97.20 | 105.69 | 112.39 | 120.54 | |
Capital Expenditures |
(0.75) | (0.21) | (0.23) | (0.34) | |
Net Current Asset Value |
75.64 | 88.89 | 95.42 | 103.26 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.01 | 0.02 | 0.03 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
11.74 | 9.52 | 9.06 | — | |
Average Payables |
3.14 | 2.68 | 3.45 | — | |
Average Inventory |
1.67 | 1.53 | 1.42 | — | |
Average Assets |
85.74 | 85.30 | 65.06 | 93.34 | |
Average Common Equity |
0.59 | 10.81 | 14.12 | — |
Columns are period end dates